MK

Mark Jeroen Kwakkenbos

AB Aimm Therapeutics B.V.: 2 patents #2 of 13Top 20%
Genentech: 1 patents #134 of 405Top 35%
Overall (2017): #126,812 of 506,227Top 30%
2
Patents 2017

Issued Patents 2017

Showing 1–2 of 2 patents

Patent #TitleCo-InventorsDate
9718874 Influenza A virus specific antibodies Hergen Spits, Tim Beaumont, Arjen Quirinus Bakker 2017-08-01
9688745 Gram-positive bacteria specific binding compounds Tim Beaumont, Eric J. Brown, John Hiroshi Morisaki, Wouter Hazenbos, Sanjeev Mariathasan +2 more 2017-06-27